Antibodies & Hybridomas — page 36 of 137
Antibodies & Hybridomas
Page 36 of 137
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 Nucleocapsid | AM223 | Chimeric | n/a | purified | 10mg | n/a |
 ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AM223 | Chimeric | n/a | purified | 100mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | A5134 | Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | A5134 | Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS46 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS46 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS46 | Mouse | n/a | purified | 10mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS46 | Mouse | n/a | purified | 100mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS47 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS47 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS47 | Mouse | n/a | purified | 1.5mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS47 | Mouse | n/a | purified | 10mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS47 | Mouse | n/a | purified | 100mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS41 | Recombinant Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS41 | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS95 | Recombinant Human | n/a | purified | 200ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS95 | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS95 | Recombinant Human | n/a | purified | 10mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Nucleocapsid | AS95 | Recombinant Human | n/a | purified | 100mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Omicron | 3A7C12 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Omicron | 3A7C12 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike Glycoprotein S1 Subunit Neutralizing | 43 | Mouse | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µg | n/a |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trimeric Spike 1 Protein | monoclonal | Chimeric Human/Mouse | n/a | unconjugated | 50 µl, 100 µl, | n/a |
 ABBEXA LTD |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trimeric Spike 1 Protein | monoclonal | Chimeric Human/Mouse | n/a | unconjugated | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trimeric Spike 1 Protein | monoclonal | Recombinant | n/a | unconjugated | 1 mg, | n/a |
ABBEXA LTD |
More Info |